|
Diagnosis
and Evaluation top |
|
|
Contents
|
|
|
| |
|
|
|
Astrocytic
Tumors
|
|
|
|
|
Jun Chen, Shu-Lan Huang, Tao Li and
Xi-Lan Chen
In vivo research in astrocytoma cell proliferation with 1H-magnetic
resonance spectroscopy: correlation with histopathology and immunohistochemistry
Neuroradiology. 2006 May;48(5):312-8. Epub
2006 Mar 22.
Abstract
|
| |
Toshinari
Misaki, Takaaki Beppu, Takashi Inoue, Kuniaki Ogasawara, Akira Ogawa,
Hiroyuki Kabasawa
Use
of fractional anisotropy value by diffusion tensor MRI for preoperative
diagnosis of astrocytic tumors: case report
Journal
of Neuro-Oncology, 70(3):
343-348, December 2004. (Abstract+)
|
|
|
Xiangsong
Z, Weian C.
Differentiation of recurrent astrocytoma from radiation necrosis: a pilot
study with 13N-NH3 PET.
J Neurooncol.
2007 May;82(3):305-11. Epub 2006 Nov 22.
PMID: 17120157 [PubMed - indexed for MEDLINE]
|
|
|
Zhang
K, Li C, Liu Y, Li L, Ma X, Meng X, Feng D
Evaluation of invasiveness of astrocytoma using 1H-magnetic resonance
spectroscopy: correlation with expression of matrix metalloproteinase-2
Neuroradiology. 2007
Nov;49(11):913-9.
Epub 2007 Sep 1
Abstract |
DBLinks | BL 7:8
|
|
|
Brainstem
Gliomas
|
|
|
|
|
Panigrahy A, Nelson Jr MD, Finlay JL, Sposto R,
Krieger MD, Gilles FH, Blüml S.
Metabolism of diffuse intrinsic brainstem gliomas in children.
Neuro Oncol. 2007
Nov 14; [Epub ahead of print]
Abstract
|
DBLinks
|
|
|
Choroid
Plexus Papilloma
|
|
|
|
D'Ambrosio
AL, O'Toole JE, Connolly ES Jr, Feldstein NA
Villous
hypertrophy versus choroid plexus papilloma: a case report demonstrating a
diagnostic role for the proliferation index
Pediatr Neurosurg. 2003 Jul;39(2):91-6
|
|
|
CNS
Lymphoma
|
|
|
| |
Neuwelt EA, Guastadisegni PE, Varallyay
P, Doolittle ND
Imaging changes and cognitive
outcome in primary CNS lymphoma after enhanced chemotherapy delivery
AJNR Am J
Neuroradiol. 2005 Feb;26(2):258-65
|
|
Soussain
C, Muldoon LL, Varallyay C, Jahnke K, Depaula L, Neuwelt EA.
Characterization and magnetic resonance imaging of a rat model of human
B-cell central nervous system lymphoma.
Clin
Cancer Res. 2007 Apr 15;13(8):2504-11.
PMID: 17438111 [PubMed - in process]
|
|
|
Taillibert S, Guillevin R, Menuel C, Sanson M,
Hoang-Xuan K, Chiras J, Duffau H
Brain lymphoma: usefulness of the magnetic resonance spectroscopy
J Neurooncol.
2008 Jan;86(2):225-9.
Epub 2007 Sep 4
Abstract |
DBLinks | BL 7:6
|
|
|
CNS
Tumors
|
|
|
|
Auer
T, Schwarcz A, Janszky J, Horvath Z, Kosztolanyi P, Doczi T.
[Application of functional MR-images acquired at low field in planning of
neurosurgical operation close to an eloquent brain area]
Ideggyogy Sz. 2007 Jan
20;60(1-2):35-40. Hungarian.
PMID: 17432092 [PubMed - in process]
|
| |
A Bizzi, U.
Danesi, B. Pollo, L. Bissola, P. Ferroli, C. Solero, A. Boiardi, G. Broggi
H-MR
Spectroscopic Imaging-guided Surgery of Brain Tumors and correlation with
Neuropathology
Proc. Int. Symp.
“New Treatments for Brain Tumors: Gene Therapy and Neural Stem Cells”,
Parma, Italy, October 17-20, 2001, Abstract
No. O-1
|
|
William G. Bradley, MD, PhD
Achieving Gross Total Resection of
Brain Tumors: Intraoperative MR Imaging Can Make a Big Difference
American Journal of Neuroradiology 23:348-349, March 2002. (PDF Full Text)
|
|
Broholm H,
Rubin I, Kruse A, Braendstrup O, Schmidt K, Skriver EB, Lauritzen M
Nitric
oxide synthase expression and enzymatic activity in human brain tumors
Clin Neuropathol. 2003 Nov-Dec;22(6):273-81
|
|
Brown
GG, Clark C, Liu TT.
Measurement of cerebral perfusion with arterial spin labeling: Part 2.
Applications.
J
Int Neuropsychol Soc. 2007 May;13(3):526-38.
PMID: 17445302 [PubMed - in process]
|
|
|
Geerts
J, Martens M, Vandevenne JE, Gelin G, Grieten M, Weyns F, Stinissen P,
Palmers Y, Wuyts J.
Functional magnetic resonance imaging for preoperative
localisation of eloquent brain areas relative to brain tumours: clinical
implementation in a regional hospital.
JBR-BTR.
2007 Jul-Aug;90(4):258-63.
Abstract
|
| |
Grosu AL,
Lachner R, Wiedenmann N, Stark S, Thamm R, Kneschaurek P, Schwaiger M, Molls M,
Weber WA
Validation
of a method for automatic image fusion (BrainLAB System) of CT data and
11C-methionine-PET data for stereotactic radiotherapy using a LINAC: first
clinical experience
Int J Radiat Oncol Biol Phys. 2003 Aug 1;56(5):1450-63
|
|
|
Hourani
R, Brant LJ, Rizk T, Weingart JD, Barker PB, Horská A.
Can proton MR spectroscopic and perfusion imaging differentiate between
neoplastic and nonneoplastic brain lesions in adults?
AJNR
Am J Neuroradiol. 2008 Feb;29(2):366-72.
Epub 2007 Nov 30
Abstract |
 Full Text |
Reprint |
DBLinks | BL 7:9
|
|
|
Jain
R, Scarpace L, Ellika S, Schultz LR, Rock JP, Rosenblum ML, Patel SC, Lee TY,
Mikkelsen T.
First-pass perfusion computed tomography: initial experience in differentiating recurrent brain tumors
from radiation effects and radiation necrosis.
Neurosurgery.
2007 Oct;61(4):778-86;
discussion 786-7.
Abstract
|
| |
Kajimoto
K, Oku N, Kimura Y, Kato H, Tanaka MR, Kanai Y, Kitagawa K, Maruno M,
Yoshimine T, Hori M, Hatazawa J.
Crossed cerebellar diaschisis: a positron emission
tomography study with L-[methyl-11C]methionine and
2-deoxy-2-[18F]fluoro-D-glucose.
Ann Nucl Med.
2007 Feb;21(2):109-13.
PMID: 17424977 [PubMed - in process]
|
|
Kuhn
MJ, Picozzi P, Maldjian JA, Schmalfuss IM, Maravilla KR, Bowen BC, Wippold FJ
2nd, Runge VM, Knopp MV, Wolansky LJ, Gustafsson L, Essig M, Anzalone N.
Evaluation of intraaxial enhancing brain tumors on magnetic resonance
imaging: intraindividual crossover comparison of gadobenate dimeglumine and
gadopentetate dimeglumine for visualization and assessment, and implications
for surgical intervention.
J Neurosurg. 2007
Apr;106(4):557-66.
PMID: 17432704 [PubMed - in process]
|
| |
S. M. Kurian, E. B. Crowell
Concordance of FDG-PET scan and MRI- spectroscopy in
primary and metastatic intracranial tumors
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1551
|
|
|
Li YD, Geng DY, Zhang QB, Jiang SH
Discrepancy between the dynamic computed tomography and t2* magnetic
resonance perfusion imaging in brain tumors: a report of 2 cases
J Comput Assist Tomogr. 2007 Nov-Dec;31(6):896-900
Abstract |
DBLinks
|
|
|
Lucignani
G.
Hints on new applications of emission tomography and magnetic resonance in
neuro-oncology.
Eur
J Nucl Med Mol Imaging. 2007 Jun 29; [Epub ahead of print] No
abstract available.
PMID: 17604987 [PubMed - as supplied by publisher]
|
|
Madhusoodanan
S, Danan D, Moise D.
Psychiatric manifestations of brain tumors: diagnostic
implications.
Expert
Rev Neurother. 2007 Apr;7(4):343-9.
PMID: 17425489 [PubMed - in process]
|
| |
Mardor Y,
Pfeffer R, Spiegelmann R, Roth Y, Maier SE, Nissim O, Berger R, Glicksman A,
Baram J, Orenstein A, Cohen JS, Tichler T
Early
Detection of Response to Radiation Therapy in Patients With Brain Malignancies
Using Conventional and High b-Value Diffusion-Weighted Magnetic Resonance
Imaging
J Clin Oncol 2003 Mar 15;21(6):1094-100
|
| |
Meyer
PT, Schreckenberger M, Spetzger U, Meyer GF, Sabri O, Setani KS, Zeggel T,
Buell U
Comparison of visual and ROI-based
brain tumour grading using 18F-FDG PET: ROC analyses
Eur J Nucl Med. 2001 Feb;28(2):165-74
|
| |
E.
A. Neuwelt, L. Konyves-Kolonics, M. Haluska
Ferumoxtran-10
enhanced MR in variety of intracranial tumors and other lesions
39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No.
488
|
| |
Jeffrey R. Petrella, MD, Lubdha M. Shah,
MD, Katy M. Harris, BS, Allen H. Friedman, MD, Timothy M. George, MD, John H.
Sampson, MD, PhD, Joseph S. Pekala, MD and James T. Voyvodic, PhD
Preoperative Functional MR Imaging Localization of
Language and Motor Areas: Effect on Therapeutic Decision Making in Patients with
Potentially Resectable Brain Tumors
Radiology 2006 (September) 240: 793-802. Published online before print July 20
2006, 10.1148/radiol.2403051153
|
| |
Pirotte B,
Goldman S, Salzberg S, Wikler D, David P, Vandesteene A, Van Bogaert P, Salmon
I, Brotchi J, Levivier M
Combined
positron emission tomography and magnetic resonance imaging for the planning of
stereotactic brain biopsies in children: experience in 9 cases
Pediatr Neurosurg 2003 Mar;38(3):146-55
|
|
|
Plesec TP, Prayson RA.
Frozen section discrepancy in the evaluation of central nervous system
tumors.
Arch Pathol
Lab Med. 2007 Oct;131(10):1532-40.
Full
Text |
Reprint
|
|
|
Prabhakar
R, Haresh KP, Ganesh T, Joshi RC, Julka PK, Rath GK.
Comparison of computed tomography and magnetic
resonance based target volume in brain tumors.
J
Cancer Res Ther. 2007 Apr-Jun;3(2):121-3.
Full
Text |
Reprint
|
DBLinks
|
|
|
Prins, Robert M. Ph.D.; Bruhn, Kevin W. Ph.D.;
Craft, Noah M.D., Ph.D.; Lin, Jia Wei M.D.; Kim, Choong-Hyun M.D., Ph.D.;
Odesa, Sylvia K. B.S.; Miller, Jeff F. Ph.D.; Liau, Linda M. M.D., Ph.D.
Central Nervous System Tumor Immunity Generated by a Recombinant
Listeria monocytogenes Vaccine Targeting Tyrosinase Related Protein-2 and
Real-Time Imaging of Intracranial Tumor Burden
Neurosurgery. 58(1):169-178, January 2006
Abstract
|
|
|
James M. Provenzale, MD, Srinivasan Mukundan,
PhD, MD and Daniel P. Barboriak, MD
Diffusion-weighted and Perfusion MR Imaging for Brain Tumor
Characterization and Assessment of Treatment Response
Radiology. 2006 Jun;239(3):632-49; DOI:
10.1148/radiol.2393042031
Abstract
|
|
Rueger
MA, Kracht LW, Hilker R, Thiel A, Sobesky J, Winkeler A, Thomas AV,
Heneka MT, Graf R, Herholz K, Heiss WD, Jacobs AH.
Role of in vivo imaging of the central nervous system
for developing novel drugs.
Q
J Nucl Med Mol Imaging. 2007 Jun;51(2):164-81.
PMID: 17420717 [PubMed - in process]
|
| |
Schwindack
C, Siminotto
E, Meyer
M, McNamara
A, Marshall
I, Wardlaw
JM, Whittle
IR
Real-time functional magnetic resonance imaging (rt-fMRI)
in patients with brain tumours: preliminary findings using motor and
language paradigms
Br J
Neurosurg. 2005 Feb;19(1):25-32
|
|
Talbot
JN, Kerrou K, Montravers F, Nataf V, Chevalme Y.
FDOPA PET has clinical utility in brain tumour imaging: a proposal for a
revision of the recent EANM guidelines.
Eur
J Nucl Med Mol Imaging. 2007 Apr 17; [Epub ahead of print] No
abstract available.
PMID: 17437107 [PubMed - as supplied by publisher]
|
|
|
Terakawa
Y, Tsuyuguchi N, Iwai Y, Yamanaka K, Higashiyama S, Takami T, Ohata K
Diagnostic Accuracy of 11C-Methionine PET for Differentiation of Recurrent
Brain Tumors from Radiation Necrosis After Radiotherapy
J
Nucl Med. 2008 Apr 15; [Epub ahead of print]
Abstract |
DBLinks | BL 7:9
|
| |
Katherine E. Warren
NMR Spectroscopy and Pediatric Brain Tumors
The Oncologist, Vol. 9, No. 3, 312–318, June 2004. (PDF Full Text)
|
|
|
Young
GS.
Advanced MRI of adult brain tumors.
Neurol Clin.
2007 Nov;25(4):947-73.
Abstract
|
|
Zamboni
SL, Loenneker T, Boltshauser E, Martin E, Il'yasov KA.
Contribution of Diffusion Tensor MR Imaging in
Detecting Cerebral Microstructural Changes in Adults with
Neurofibromatosis Type 1.
AJNR
Am J Neuroradiol. 2007 Apr;28(4):773-6.
PMID: 17416837 [PubMed - in process]
|
|
|
Diffuse
Astrocytoma
|
|
|
|
Bela Bodey, Vivian Bodey, Stuart E. Siegel,
Hans E. Kaiser
Mage-1, a cancer-testis antigen, and p53 expression in
childhood astrocytomas as an indicator of tumor progression
Proceedings
of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. 158
|
|
|
Ehrenfeld CE, Maschke M, Dörfler A, Reinhardt
V, Koeppen S
Is stereotactic biopsy a reliable method to differentiate tumor from
radiation necrosis?
Clin Neuropathol 2002 Jan-Feb;21(1):9-12
Abstract |
DBLinks | BL
1:3
|
|
Schlemmer
HP, Bachert P, Henze M, Buslei R, Herfarth KK, Debus J, van KG
Differentiation
of radiation necrosis from tumor progression using proton magnetic resonance
spectroscopy
Neuroradiology 2002 Mar;44(3):216-22
|
|
|
Edema
|
|
|
|
Kimura
T, Ohkubo M, Igarashi H, Kwee IL, Nakada T.
Increase in glutamate as a sensitive indicator of extracellular matrix
integrity in peritumoral edema: a 3.0-tesla proton magnetic resonance
spectroscopy study.
J Neurosurg. 2007
Apr;106(4):609-13.
PMID: 17432711 [PubMed - in process]
|
|
|
Enhancement
|
|
|
|
|
Kamel
MH, Kelleher M, O'riordan C, Keohane C, O'sullivan M.
CT and MRI 'ring sign' may be due to demyelination: diagnostic pitfall.
Br J Neurosurg.
2007 Jun;21(3):309-11.
PMID: 17612927 [PubMed - in process]
|
|
|
Glioblastoma
|
|
|
|
Burger PC, Dubois PJ, Schold SC Jr, Smith KR Jr, Odom GL, Crafts
DC, Giangaspero F
Computerized
tomographic and pathologic studies of the untreated, quiescent, and
recurrent glioblastoma multiforme
J Neurosurg. 1983 Feb;
58(2): 159-69
|
|
Hochberg FH,
Pruitt A
Assumptions
in the radiotherapy of glioblastoma
Neurology. 1980 Sep; 30(9): 907-11
|
|
|
Jung
CS, Foerch C, Schänzer A, Heck A, Plate KH, Seifert V, Steinmetz H, Raabe
A, Sitzer M.
Serum GFAP is a diagnostic marker for glioblastoma multiforme.
Brain.
2007 Nov 12; [Epub ahead of print]
Abstract
|
DBLinks
|
| |
Samira Guccione,
Yishan Yang, Ron Homer, Steven Chang, Griff Harsh, Scott Atlas, Mark Bednarski
The use of MRI in patients with glioblastoma
multiforme to identify regions of vascular permeability for genomic analysis
Proceedings
of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. 2958
|
|
|
Laprie A, Catalaa I, Cassol E, McKnight TR,
Berchery D, Marre D, Bachaud JM, Berry I, Moyal EC
Proton magnetic resonance spectroscopic imaging in newly diagnosed
glioblastoma: predictive value for the site of postradiotherapy relapse in a
prospective longitudinal study
Int J Radiat Oncol Biol Phys. 2008 Mar 1; 70(3):773-81; Epub 2008 Feb 6
Abstract |
DBLinks | BL 7:4
|
| |
Principi M, Italiani M, Guiducci A, Aprile I, Muti M,
Giulianelli G, Ottaviano P
Perfusion
MRI in the evaluation of the relationship between tumour growth, necrosis and
angiogenesis in glioblastomas and grade 1 meningiomas
Neuroradiology 2003 Apr;45(4):205-11
|
|
|
Sanal
HT, Bulakbasi N, Kocaoglu M, Onguru O, Chen L.
Giant Infantile Gliosarcoma: Magnetic Resonance Imaging Findings
J Child Neurol. 2008 Apr 10; [Epub ahead of print]
Abstract |
Reprint |
DBLinks | BL 7:8
|
|
|
Shaan M. Raza, B.S.; Frederick F. Lang, M.D.; Bharat B.
Aggarwal, Ph.D.; Gregory N. Fuller, Ph.D., M.D.; David M. Wildrick, Ph.D.; Raymond
Sawaya,M.D.
Necrosis and Glioblastoma: A Friend or a Foe?
A Review and a Hypothesis
Neurosurgery. 51(1):2-13, July 2002
Abstract
|
DBLinks | BL 1:1
|
|
|
Spence
AM, Muzi M, Swanson KR, O'Sullivan F, Rockhill JK, Rajendran JG, Adamsen TC,
Link JM, Swanson PE, Yagle KJ, Rostomily RC, Silbergeld DL, Krohn KA
Regional Hypoxia in Glioblastoma Multiforme Quantified with
[18F]Fluoromisonidazole Positron Emission Tomography before Radiotherapy:
Correlation with Time to Progression and Survival
Clin Cancer Res. 2008 May 1;14(9):2623-30
Abstract |
DBLinks | BL 7:10
|
| |
Kevin
S. Tralins, MD, James G. Douglas, MD, MS, Keith J. Stelzer, MD, PhD, David
A. Mankoff, MD, Daniel L. Silbergeld, MD, Robert Rostomilly, MD, Sharon Hummel,
MS, Jeff Scharnhorst, BS, Kenneth A. Krohn, PhD and Alexander M. Spence, MD
Volumetric Analysis of 18F-FDG PET
in Glioblastoma Multiforme: Prognostic Information and Possible Role in
Definition of Target Volumes in Radiation Dose Escalation
Journal of Nuclear Medicine Vol. 43 No. 12 1667-1673
|
|
|
Saxena
V, Gonzalez-Gomez I, Laug WE.
A Non-invasive, In Vivo Technique for Monitoring
Vascular Status of Glioblastoma During Angiogenesis.
Technol
Cancer Res Treat. 2007 Dec;6(6):641-50.
Abstract
|
DBLinks
|
|
Wallner
KE, Galicich JH, Krol G, Arbit E, Malkin MG
Patterns
of failure following treatment for glioblastoma multiforme and anaplastic
astrocytoma
Int J Radiat Oncol Biol Phys. 1989 Jun; 16(6): 1405-9
|
|
Zhang R,
Tremblay TL, McDermid A, Thibault P, Stanimirovic D
Identification
of differentially expressed proteins in human glioblastoma cell lines and tumors
Glia 2003 Apr 15;42(2):194-208
|
|
|
Gliomas
|
|
|
|
|
Atkinson M, Juhasz C, Shah J, Guo X, Kupsky W,
Fuerst D, Johnson R, Watson C
Paradoxical imaging findings in cerebral gliomas
J Neurol Sci. 2008 Feb 5; [Epub ahead of print]
Abstract |
DBLinks | BL 7:4
|
|
|
Brekke
C, Williams SC, Price J, Thorsen F, Modo M.
Cellular multiparametric MRI of neural stem cell therapy in a rat glioma
model.
Neuroimage. 2007 Jun 14; [Epub
ahead of print]
PMID: 17613248 [PubMed - as supplied by publisher]
|
| |
Cao Y, Tsien CI, Nagesh V, Junck L, Ten Haken
R, Ross BD, Chenevert TL, Lawrence TS
Clinical investigation survival
prediction in high-grade gliomas by MRI perfusion before and during early stage
of RT
Int
J Radiat Oncol Biol Phys. 2005 Nov 17; [Epub ahead of
print]
|
| |
De Wit MC, De Bruin HG, Eijkenboom W, Sillevis Smitt PA, Van Den Bent
MJ
Immediate post-radiotherapy changes in malignant glioma can
mimic tumor progression
Neurology. 2004 Aug 10;63(3):535-7
|
| |
De
Witte O, Goldberg I, Wikler D, Rorive S, Damhaut P, Monclus M, Salmon I,
Brotchi J, Goldman S
Positron emission tomography with
injection of methionine as a prognostic factor in glioma
J
Neurosurg. 2001 Nov;95(5):746-50
|
| |
E.
Galanis, M. J. Maurer, K. V. Ballman, J. O'Fallon, R. Sykora, R. Castillo,
J. C. Buckner, B. J. Erickson
Validation of neuroradiologic response assessment in
gliomas: RECIST (1D) vs 2D measurements vs computer-assisted tumor area vs
volume
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003. Abstract No.
423
|
|
Hakyemez B, Erdogan C, Ercan I, Ergin N, Uysal S, Atahan
S
High-grade and low-grade gliomas: differentiation by
using perfusion MR imaging
Clin
Radiol. 2005 Apr;60(4):493-502
|
|
|
Kato
T, Shinoda J, Nakayama N, Miwa K, Okumura A, Yano H, Yoshimura S, Maruyama
T, Muragaki Y, Iwama T.
Metabolic Assessment of Gliomas Using 11C-Methionine, [18F]
Fluorodeoxyglucose, and 11C-Choline Positron-Emission Tomography
AJNR
Am J Neuroradiol. 2008 Apr 3; [Epub ahead of print]
Abstract |
DBLinks | BL 7:8
|
|
Kelly PJ,
Daumas-Duport C, Scheithauer BW, Kall BA, Kispert DB
Stereotactic
histologic correlations of computed tomography- and magnetic resonance
imaging-defined abnormalities in patients with glial neoplasms
Mayo Clin Proc. 1987 Jun; 62(6): 450-9
|
|
Kircher
MF, Mahmood U, King RS, Weissleder R, Josephson L
A
multimodal nanoparticle for preoperative magnetic resonance imaging and
intraoperative optical brain tumor delineation
Cancer Res. 2003 Dec 1;63(23):8122-5
|
| |
Kumar
AJ, Leeds NE, Fuller GN, Van Tassel P, Maor MH, Sawaya RE, Levin VA
Malignant
gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced
necrosis of the brain after treatment
Radiology. 2000 Nov;217(2):377-84 (PDF Full Text)
|
| |
Kuznetsov YE, Caramanos Z, Antel SB, Preul MC, Leblanc R,
Villemure JG, Pokrupa R, Olivier A, Sadikot A, Arnold DL
Proton magnetic resonance spectroscopic imaging can
predict length of survival in patients with supratentorial gliomas
Neurosurgery. 2003 Sep;53(3):565-76
|
| |
Lichy MP,
Bachert P, Henze M, Lichy CM, Debus J, Schlemmer HP
Monitoring
individual response to brain-tumour chemotherapy: proton MR spectroscopy in a
patient with recurrent glioma after stereotactic radiotherapy
Neuroradiology. 2003 Dec 18 [Epub ahead of print].
|
|
|
Lu
H, Pollack E, Young R, Babb JS, Johnson G, Zagzag D, Carson R, Jensen JH,
Helpern JA, Law M.
Predicting Grade of Cerebral Glioma Using
Vascular-Space Occupancy MR Imaging.
AJNR
Am J Neuroradiol. 2007 Nov 1; [Epub ahead of print]
Abstract
|
| |
Yael
Mardor, Roberto Spiegelmann, Yiftach Roth, Arie Orenstein, Stephan E. Maier,
Ouzi Nissim, Zvi Ram, Jacob Baram, Thomas Tichler, Raphael Pfeffer
Pre-treatment prediction of brain tumor response to
radiation therapy using high diffusion-weighted MRI
Proceedings of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. 2547
|
|
Murphy PS, Viviers L, Abson C, Rowland IJ, Brada M, Leach
MO, Dzik-Jurasz AS
Monitoring temozolomide treatment of low-grade glioma
with proton magnetic resonance spectroscopy
Br J Cancer. 2004 Feb 23;90(4):781-6
|
|
M.V. Padma, S. Said,
M. Jacobs, D.R. Hwang, K. Dunigan, M. Satter, B. Christian, J. Ruppert, T.
Bernstein, G. Kraus, J.C. Mantil
Prediction of Pathology and Survival by FDG PET in Gliomas
Journal of Neuro-Oncology, 64 (3): 227-237, September 2003
|
| |
Susan
Pannullo, D. C
Shungu, R. L DeLaPaz, M. Odaimi, J. Serventi, L. Heller, C. M Balmaceda
Use
of magnetic resonance spectroscopy (MRS) in malignant gliomas treated with
temozolomide (TMZ)
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
2101
|
| |
Michail Plotkin, Julia Eisenacher,
Harald
Bruhn, Reinhard Wurm, Roger Michel, Florian Stockhammer, Annelie
Feußner,
Oliver Dudeck, Peter Wust, Roland Felix, Holger Amthauer
123I-IMT
SPECT and 1HMR-Spectroscopy at 3.0T in the Differential
Diagnosis of Recurrent or Residual Gliomas: A Comparative Study
J Neurooncol, 70
(1):49-58, Oct. 2004.
(Abstract+)
|
|
Scott
JN, Brasher PM, Sevick RJ, Rewcastle NB, Forsyth PA
How
often are nonenhancing supratentorial gliomas malignant? A population
study
Neurology. 2002 Sep
24;59(6):947-9
|
|
Takahashi Y,
Imahori Y, Mineura K
Prognostic
and therapeutic indicator of fluoroboronophenylalanine positron emission
tomography in patients with gliomas
Clin Cancer Res. 2003 Dec 1;9(16):5888-95
|
|
|
Tanwar MK, Gilbert MR, Holland EC.
Gene expression microarray analysis
reveals YKL-40 to be a potential serum marker for malignant character in human
glioma
Cancer Res 2002 Aug 1;62(15):4364-8
Abstract |
Full Text |
Reprint |
DBLinks | BL 1:2
|
|
Vos
MJ, Uitdehaag BM, Barkhof F, Heimans JJ, Baayen HC, Boogerd W, Castelijns
JA, Elkhuizen PH, Postma TJ
Interobserver
variability in the radiological assessment of response to chemotherapy in glioma
Neurology 2003 Mar 11;60(5):826-30
|
|
|
Gliomas
(High-Grade)
|
|
|
|
|
Burnet NG, Lynch AG, Jefferies SJ, Price SJ,
Jones PH, Antoun NM, Xuereb JH, Pohl U.
High grade glioma: Imaging combined with pathological grade defines
management and predicts prognosis
Radiother
Oncol. 2007 Nov 26; [Epub ahead of print]
Abstract |
DBLinks
|
|
|
Adília Hormigo, Bin Gu,
Sasan Karimi, Elyn Riedel, Katherine S.
Panageas, Mark A. Edgar, Meena K. Tanwar, Jasti
S. Rao, Martin Fleisher, Lisa M. DeAngelis
and Eric C. Holland
YKL-40 and Matrix Metalloproteinase-9 as Potential Serum Biomarkers for
Patients with High-Grade Gliomas
Clin
Cancer Res. 2006 Oct 1;12(19):5698-704.
|
|
|
Shirahata M, Iwao-Koizumi K, Saito S, Ueno N,
Oda M, Hashimoto N, Takahashi JA, Kato K
Gene expression-based molecular diagnostic system for malignant gliomas is
superior to histological diagnosis
Clin
Cancer Res. 2007 Dec 15;13(24):7341-56
Abstract |
DBLinks
|
|
|
V.
Vallejos, C.
Balaña, M. Fraile,
Y. Roussos, J. Capellades, P. Cuadras, R. Ballester, A. Ley, A. Arellano,
R. Rosell
Use of 201Tl SPECT Imaging to Assess the Response to Therapy in Patients with
High Grade Gliomas
Journal of Neuro-Oncology, 59 (1): 81-90, August 2002
Abstract |
Reprint |
DBLinks | BL
1:3
|
|
|
Gliomas
(Low-Grade)
|
|
|
|
|
Danchaivijitr
N, Waldman AD, Tozer DJ, Benton CE, Brasil Caseiras G, Tofts PS, Rees JH, Jäger
HR.
Low-grade gliomas: do changes in rCBV measurements at longitudinal
perfusion-weighted MR imaging predict malignant transformation?
Radiology. 2008 Apr;247(1):170-8.
Abstract |
DBLinks | BL 7:8
|
| |
De
Witte O, Oulad Ben Taib N, Branle F, Rorive S, Brotchi J, Goldman S
Contribution of PET to the
management of patients with low-grade glioma
Neurochirurgie.
2004 Sep;50(4):468-73
|
|
|
Einar Goebell, MD, Susanne Paustenbach, Ole Vaeterlein, MD, Xiao-Qi Ding,
PhD, MD, Oliver Heese, MD, Jens Fiehler, MD, Thomas Kucinski, MD,
Christian Hagel, MD, Manfred Westphal, MD and Hermann Zeumer, MD
Low-Grade and Anaplastic Gliomas: Differences in Architecture Evaluated
with Diffusion-Tensor MR Imaging
Radiology, 2006;239:217-222;
Published online before print February 16,
2006; DOI: 10.1148/radiol.2383050059
Abstract
|
|
|
Guillevin R, Menuel C, Duffau H, Kujas M,
Capelle L, Aubert A, Taillibert S, Idbaih A, Pallud J, Demarco G, Costalat
R, Hoang-Xuan K, Chiras J, Vallée JN
Proton magnetic resonance spectroscopy predicts proliferative activity in
diffuse low-grade gliomas
J Neurooncol.
2007 Dec 28; [Epub ahead of print]
Abstract |
DBLinks | BL 7:3
|
|
|
Gupta R, Mohindra S, Gupta K
Demyelination or low-grade glioma? A diagnostic dilemma
Surg Neurol.
2008 Feb 22; [Epub ahead of print]
Abstract |
DBLinks | BL 7:6
|
| |
Marcus
Henze, MD, Ashour Mohammed, PhD, Heinz P. Schlemmer, MD, Klaus K.
Herfarth, MD, Simone Hoffner, MD, Sabine Haufe, MD, Walter Mier, PhD,
Michael Eisenhut, PhD, Jürgen Debus, MD, PhD and Uwe Haberkorn, MD
PET
and SPECT for Detection of Tumor Progression in Irradiated Low-Grade
Astrocytoma: A Receiver-Operating-Characteristic Analysis
Journal
of Nuclear Medicine, April 1 2004, Volume 45, Issue 4, Pages 579-586
|
| |
Herholz
K, Holzer T, Bauer B, Schroder R, Voges J, Ernestus RI, Mendoza G,
Weber-Luxenburger G, Lottgen J, Thiel A, Wienhard K, Heiss WD
11C-methionine
PET for differential diagnosis of low-grade gliomas
Neurology.
1998 May;50(5):1316-22
|
| |
Mandonnet
E, Delattre JY, Tanguy ML, Swanson KR, Carpentier AF, Duffau H, Cornu
P, Van Effenterre R, Alvord EC Jr, Capelle L
Continuous growth of mean
tumor diameter in a subset of grade II gliomas
Ann
Neurol. 2003 Apr;53(4):524-8
|
|
|
Law, Meng M.D.; Oh, Sarah M.D.; Johnson, Glyn
Ph.D.; Babb, James S. Ph.D.; Zagzag, David M.D., Ph.D.; Golfinos, John M.D.;
Kelly, Patrick J. M.D.
Perfusion Magnetic Resonance Imaging Predicts Patient Outcome as an
Adjunct to Histopathology: A Second Reference Standard in the Surgical and
Nonsurgical Treatment of Low-grade Gliomas
Neurosurgery. 58(6):1099-1107, June 2006
Abstract
| Full
Text |
Reprint
|
| |
Novak L, Molnar P, Lengyel Z, Tron L
Does increased 18FDG uptake reflect malignant
transformation of a low-grade glioma? A diagnostic dilemma
Neurol
India. 2005 Mar;53(1):112-4. (PDF
Full Text)
|
| |
Nuutinen
J, Sonninen P, Lehikoinen P, Sutinen E, Valavaara R, Eronen E,
Norrgard S, Kulmala J, Teras M, Minn H
Radiotherapy
treatment planning and long-term follow-up with [(11)C]methionine PET
in patients with low-grade astrocytoma
Int
J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):43-52
|
|
Pallud J, Mandonnet E, Duffau H, Kujas M, Guillevin
R, Galanaud D, Taillandier L, Capelle L.
Prognostic value of initial magnetic resonance imaging growth rates for World
Health Organization grade II gliomas.
Ann Neurol. 2006 Sep 18;60(3):380-383 [Epub ahead of print]
Abstract
|
| |
Pirzkall
A, Nelson SJ, McKnight TR, Takahashi MM, Li X, Graves EE, Verhey LJ,
Wara WW, Larson DA, Sneed PK
Metabolic
imaging of low-grade gliomas with three-dimensional magnetic resonance
spectroscopy
Int
J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1254-64
|
|
Ribom
D, Larsson A, Pietras K, Smits A
Growth
factor analysis of low-grade glioma CSF: PDGF and VEGF are not detectable
Neurol
Sci. 2003 Jun;24(2):70-3
|
|
Ribom
D, Westman-Brinkmalm A, Smits A, Davidsson P
Elevated levels of
alpha-2-Heremans-Schmid glycoprotein in CSF of patients with low-grade gliomas
Tumour
Biol. 2003 Mar-Apr;24(2):94-9
|
|
Ribom
D, Engler H, Blomquist E, Smits A
Potential
significance of (11)C-methionine PET as a marker for the radiosensitivity of
low-grade gliomas
Eur
J Nucl Med Mol Imaging. 2002 May;29(5):632-40. Epub 2002 Mar 5
|
|
Ribom
D, Eriksson A, Hartman M, Engler H, Nilsson A, Langstrom B, Bolander H,
Bergstrom M, Smits A
Positron
emission tomography (11)C-methionine and survival in patients with low-grade
gliomas
Cancer.
2001 Sep 15;92(6):1541-9
|
|
Walker C, du Plessis DG, Fildes D, Haylock B,
Husband D, Jenkinson MD, Joyce KA, Broome J, Kopitski K, Prosser J, Smith T,
Vinjamuri S, Warnke PC
Correlation of molecular genetics
with molecular and morphological imaging in gliomas with an oligodendroglial
component
Clin
Cancer Res. 2004 Nov 1;10(21):7182-91
|
|
|
Gliomatosis
Cerebri
|
|
|
| |
Galanaud
D, Chinot O, Nicoli F, Confort-Gouny S, Le Fur Y, Barrie-Attarian M,
Ranjeva JP, Fuentes S, Viout P, Figarella-Branger D, Cozzone PJ
Use
of proton magnetic resonance spectroscopy of the brain to differentiate
gliomatosis cerebri from low-grade glioma
J Neurosurg 2003
Feb;98(2):269-76
|
|
|
Markers
|
|
|
|
|
Edward
R. Smith, MD; David Zurakowski, PhD; Ali Saad, MD; R. Michael Scott, MD;
Marsha A. Moses, PhD
Urinary Biomarkers Predict Brain Tumor Presence and
Response to Therapy
American Association of Neurological Surgeons 76th Annual Meeting: Abstract
629. Presented April 28, 2008
Abstract |
 News |
DBLinks | BL 7:10
|
|
|
Medulloepithelioma
|
|
|
|
Rajan Syal, Jaypal Reddy S, Raj Kumar, Isha Tyagi,
A.A. Wani Abrar, Narender Krishnani, Asht M. Mishra, Rakesh K. Gupta
Unusual Clinical and MRI Features of a Cerebellopontine
Angle Medulloepithelioma
Pediatr Neurosurg. 2006 Aug;42(5):299-303
Abstract
|
|
|
Medulloblastoma
|
|
|
|
CM Coffin, JT Braun, MR Wick and LP Dehner
A clinicopathologic and immunohistochemical analysis
of 53 cases of medulloblastoma with emphasis on synaptophysin expression
Modern Pathology, 1990, Vol 3, Issue 2, 164-170 (Laboratory
Investigation,
Abstract)
|
|
Yuksel
M, Lutterbey G, Biersack HJ, Elke U, Hasan C, Gao Z, Bode U, Ezziddin S.
111In-pentetreotide scintigraphy in medulloblastoma: a comparison with
magnetic resonance imaging.
Acta Oncol.
2007;46(1):111-7.
PMID: 17438713 [PubMed - in process]
|
|
|
Meningioma
|
|
|
|
Ahmed
SN, Scozzafava J.
Images in clinical medicine. Meningioma.
N Engl J
Med. 2007 Apr 19;356(16):e14. No abstract available.
PMID: 17442901 [PubMed - indexed for MEDLINE]
|
|
Henze M, Dimitrakopoulou-Strauss A, Milker-Zabel S, Schuhmacher J,
Strauss LG, Doll J, Macke HR, Eisenhut M, Debus J, Haberkorn U
Characterization of 68Ga-DOTA-D-Phe1-Tyr3-Octreotide
Kinetics in Patients with Meningiomas
J
Nucl Med. 2005 May;46(5):763-9.
|
|
|
Owen
CM, Schaller C, Binder DK.
The madness of Dionysus: a
neurosurgical perspective on Friedrich Nietzsche.
Neurosurgery. 2007
Sep;61(3):626-31;
discussion 631-2.
Full
Text |
Reprint
|
|
Stenzel W, Rohn G, Miletic H, Radner H, Deckert M,
Ernestus RI.
Diagnostic impact of
ornithine decarboxylase in meningiomas
J Neurooncol. 2004 Jan;66(1-2):59-64.
|
|
|
Zhang
H, Rödiger LA, Shen T, Miao J, Oudkerk M
Perfusion MR imaging for differentiation of benign and malignant meningiomas
Neuroradiology. 2008
Apr 1; [Epub ahead of print]
Abstract |
Full Text |
Reprint |
DBLinks | BL 7:8
|
|
|
Metastatic
Tumors
|
|
|
|
Dieta
Brandsma, Martin J.B. Taphoorn, Jaap C. Reijneveld, Thomas M. Nas, Emile
E. Voest, Klaas Nicolay, Erwin Blezer
MR Imaging of Mouse Leptomeningeal Metastases
Journal of Neuro-Oncology, 68 (2): 123-130, June 2004. (Abstract+)
|
|
Kimura T, Sako K, Tanaka K, Gotoh T, Yoshida H, Aburano T,
Tanaka T, Arai H, Nakada T
Evaluation of the response of
metastatic brain tumors to stereotactic radiosurgery by proton magnetic
resonance spectroscopy, 201TlCl single-photon emission computerized tomography,
and gadolinium-enhanced magnetic resonance imaging
J Neurosurg. 2004 May;100(5):835-41
|
|
|
Seute T, Leffers P, Ten Velde GP, Twijnstra A.
Detection of brain metastases from small cell lung cancer : consequences
of changing imaging techniques (CT versus MRI)
Cancer. 2008 Feb 29; [Epub
ahead of print]
Abstract |
DBLinks | BL 7:6
|
|
|
Neuroblastoma
|
|
|
|
Pearl GS,
Takei Y
Cerebellar
"neuroblastoma": nosology as it relates to medulloblastoma
Cancer.
1981 Feb 15;47(4):772-9
|
|
M
Lindskog, P Kogner, F Ponthan, P Schweinhardt, B Sandstedt, T Heiden, G
Helms and C Spenger
| |
